Igentify
PrivateLast Round
Series A
Sep 16, 2019
Total Funding Raised
$10.55M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Igentify operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Series A round in September 2019.
Igentify is a health tech company that provides a digital platform for genetic counseling, automating workflows for clinical and non-clinical genetic testing.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Workflow Automation, Medical AI, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Igentify Comparables
Compare Igentify with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| My Gene Counsel | 83% | |
| Genetics Adviser | 82% | |
| Metis Genetics | 81% |
For institutional investors. Book with your work email.
Igentify Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 16, 2019 | ||||
| Grant | Aug 1, 2019 | ||||
| Grant | Jul 8, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Igentify Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Israel Innovation Authority | Grant |
| BIRD Foundation | Grant |
| National Institute of Standards and Technology | Grant |
| aMoon | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 52% MoM.
- Aug 20, 2026
Monthly visitors grew 3244% MoM, reaching 9.7K.
For institutional investors. Book with your work email.
Igentify Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Igentify's valuation, stock price, and market status.
Is Igentify a public or private company?
Igentify is a private company.
What is the current stock price of Igentify?
Igentify is a private company, so its shares have no public market price. Caplight tracks Igentify's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Igentify worth (valuation)?
Valuation information for Igentify is not publicly available.
Can I buy Igentify stock?
Igentify shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Igentify's last funding round?
Igentify's most recent funding round was Series A on September 16, 2019.
Who are the main investors in Igentify?
Key investors in Igentify include European Union's Horizon Research and Innovation program, BIRD Foundation, aMoon.
Will Igentify IPO soon?
No public IPO plans have been announced for Igentify.
How can I track Igentify secondary market activity?
Caplight tracks bids, offers, and trades in Igentify's shares on secondary markets.